HHS said “the individuals who were fully vaccinated earliest in the vaccination rollout” will likely be the first ones who are eligible for boosters, including nursing homes residents, healthcare workers and Americans age 65 and older.
HHS said its plan is contingent upon FDA approval for COVID-19 boosters, which hasn’t been granted yet. The agency amended the emergency use authorizations for Pfizer’s and Moderna’s COVID-19 vaccines Aug. 12, allowing for a third dose in immunocompromised people, but not yet for the rest of the population.
“We also anticipate booster shots will likely be needed for people who received the Johnson & Johnson vaccine,” HHS said in a statement. “Administration of the J&J vaccine did not begin in the U.S. until March 2021, and we expect more data on J&J in the next few weeks. With those data in hand, we will keep the public informed with a timely plan for J&J booster shots as well.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
